IL-1β-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1

European Journal of Immunology

Volumn 32, Issue 12, 2002, Pages 3689-3698

  Neumann, Detlef ^a   Lienenklaus, Stefan ^a   Rosati, Olaf ^a   Martin, Michael U ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Akt; IL 1; IRAK 1; p38 MAPK; Protein kinase B

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; ENZYME INHIBITOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL KINETICS; CELL LINE; CELL TYPE; COMPLEX FORMATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL STRAIN 3T3; DRUG ANTAGONISM; DRUG EFFECT; KINETICS; METABOLISM; MOUSE; PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANDROSTADIENES; ANIMALS; APOPTOSIS; CELL LINE; ENZYME INHIBITORS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-18; INTERLEUKIN-2; KINETICS; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, IMMUNOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 0036882836     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO;2-X     Document Type: Article

References (42)

1. O'Neill, L. A. and Dinarello, C. A., The IL-1 receptor/toll-like superfamily: crucial receptors for inflammation and host defense. Immunol. Today 2000. 21: 206-209.
2. Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L. and Tong, L., Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000. 408: 111-115.
3. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. and Cao, Z., MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997. 7: 837-847.
4. Muzio, M., Ni, J., Feng, P. and Dixit, V. M., IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997. 278: 1612-1615.
5. Horng, T., Barton, G. M. and Medzhitov, R., TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2001. 2: 835-841.
6. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T., McMurray, D., Smith, D. E., Sims, J. E., Bird, T. A. and O'Neill, L. A., Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001. 413: 78-83.
7. Bowie, A. and O'Neill, L. A., The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 2000. 67: 508-514.
8. Martin, M. U. and Kollewe, C., Interleukin-1 receptor-associated kinase-1 (IRAK-1): A self-regulatory adaptor molecule in the signaling cascade of the Toll/IL-1 receptor family. Sign. Transd. 2001. 1-2: 37-50.
9. Schmidt, A., Caron, E. and Hall, A., Lipopolysaccharide-induced activation of beta 2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase. Mol. Cell Biol. 2001. 21: 438-448.
10. Palsson McDermott, E. and O'Neill, L. A., Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6 and TAK-1. J. Biol. Chem. 2001. 13: 7808-7815.
11. Palsson, E. M., Popoff, M., Thelestam, M. and O'Neill, L. A. J., Divergent roles for Ras and Rap in the activation of p38 mitogenactivated protein kinase by interleukin-1. J. Biol. Chem. 2000. 275: 7818-7825.
12. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J. and Chen, Z. J., TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001. 412: 346-351.
13. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J. and Davis, R. J., Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995. 270: 7420-7426.
14. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B. and Davis, R. J., MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 1996. 16: 1247-1255.
15. Reddy, S. A., Huang, J. H. and Liao, W. S., Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NF kappa B and AP-1 activation. J. Biol. Chem. 1997. 272: 29167-29173.
16. Marmiroli, S., Bavelloni, A., Faenza, I., Sirri, A., Ognibene, A., Cenni, V., Tsukada, J., Koyama, Y., Ruzzene, M., Ferri, A., Auron, P. E., Toker, A. and Maraldi, N. M., Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 1998. 438: 49-54.
17. Sizemore, N., Leung, S. and Stark, G. R., Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappa B p65/RelA subunit. Mol. Cell Biol. 1999. 19: 4798-4805.
18. Arbibe, L., Mira, J. P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J. and Knaus, U. G., Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 2000. 1: 533-540.
19. Burgering, B. M. and Coffer, P. J., Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995. 376: 599-602.
20. Chan, T. O., Rittenhouse, S. E. and Tsichlis, P. N., AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 1999. 68: 965-1014.
21. Guo, F. and Wu, S., IRAK-2 and PI 3-kinase synergistically activate NF-kappa B and AP-1. Inflammation 2000. 24: 305-316.
22. Lee, J., Mira-Arbibe, L. and Ulevitch, R. J., TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukoc. Biol. 2000. 68: 909-915.
23. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z. and Matsumoto, K., The kinase TAK1 can activate the NIK-I kappa B as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999. 398: 252-256.
24. Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J. and Matsumoto, K., TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 2000. 5: 649-658.
25. Takaesu, G., Ninomiya-Tsuji, J., Kishida, S., Li, X., Stark, G. R. and Matsumoto, K., Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol. Cell Biol. 2001. 21: 2475-2484.
26. Wang, Q., Dziarski, R., Kirschning, C. J., Muzio, M. and Gupta, D., Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 2001. 69: 2270-2276.
27. Madrid, L. V., Mayo, M. W., Reuther, J. Y. and Baldwin, A. S., Jr., Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the I kappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 2001. 276: 18934-18940.
28. Ardeshna, K. M., Pizzey, A. R., Devereux, S. and Khwaja, A., The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000. 96: 1039-1046.
29. Monick, M. M., Carter, A. B., Robeff, P. K., Flaherty, D. M., Peterson, M. W. and Hunninghake, G. W., Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 2001. 166: 4713-4720.
30. Madge, L. A. and Pober, J. S., A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NF kappa B in human endothelial cells. J. Biol. Chem. 2000. 275: 15458-15465.
31. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin, A. S., Jr. and Mayo, M. W., Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappa B. Mol. Cell Biol. 2000. 20: 1626-1638.
32. Greene, C. and O'Neill, L., Interleukin-1 receptor-associated kinase and TRAF-6 mediate the transcriptional regulation of interleukin-2 by interleukin-1 via NF kappa B but unlike interleukin-1 are unable to stabilise interleukin-2 mRNA. Biochim. Biophys. Acta 1999. 1451: 109-121.
33. Kalli, K., Huntoon, C., Bell, M. and McKean, D. J., Mechanism responsible for T cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappa B. Mol. Cell Biol. 1998. 18: 3140-3148.
34. Georganas, C., Liu, H., Perlman, H., Hoffmann, A., Thimmapaya, B. and Pope, R. M., Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J. Immunol. 2000. 165: 7199-7206.
35. Lauder, A., Castellanos, A. and Weston, K., c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis. Mol. Cell Biol. 2001. 21: 5797-5805.
36. Jensen, L. E. and Whitehead, A. S., IRAK1b, a novel alternative splice variant of interleukin-1 recptor associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J. Biol. Chem. 2001. 276: 29037-29044.
37. Wesche, H., Gao, X., Li, X., Kirschning, C. J., Stark, G. R. and Cao, Z., IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 1999. 274: 19403-19410.
38. Knop, J. and Martin, M. U., Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity. FEBS Lett. 1999. 448: 81-85.
39. Maschera, B., Ray, K., Burns, K. and Volpe, F., Overexpression of an enzymatically inactive niterleukin-1 receptor-associated kinase activates nuclear factor-κB. Biochem. J. 1999. 339: 227-231.
40. Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Funaki, M., Inukai, K., Fukushima, Y., Kikuchi, M., Oka, Y. and Asano, T., MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J. Biol. Chem. 2001. 276: 19800-19806.
41. Kanakaraj, R, Schafer, P. H., Cavender, D. E., Wu, Y., Ngo, K., Grealish, P. F., Wadsworth, S. A., Peterson, P. A., Siekierka, J. J., Harris, C. A. and Fung-Leung, W. P., Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 1998. 187: 2073-2079.
42. Kanakaraj, P., Ngo, K., Wu, Y., Angulo, A., Ghazal, P., Harris, C. A., Siekierka, J. J., Peterson, P. A. and Fung-Leung, W. P., Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 1999. 189: 1129-1138.